GNH USA

USA — NDC

CPDA-1 17.3 mg/63mL

CPDA-1 17.3 mg/63mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine

Anticoagulant Citrate Phosphate Dextrose Adenine
CPDA-1
SOLUTION
17.3 mg/63mL

Request sourcing

1
Pack/s

What is Anticoagulant Citrate Phosphate Dextrose Adenine?

CPDA-1 17.3 mg/63mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, aiding in blood storage and transfusion. Ideal for medical facilities requiring reliable blood preservation.

What is Anticoagulant Citrate Phosphate Dextrose Adenine used for?

CPDA-1 17.3 mg/63mL is primarily used to preserve blood components during storage. This anticoagulant solution helps maintain the quality and viability of blood for transfusion purposes. It is commonly used in hospitals and blood banks to ensure the safety and efficacy of stored blood.

What are the side effects of Anticoagulant Citrate Phosphate Dextrose Adenine?

CPDA-1 17.3 mg/63mL works by preventing blood from clotting, allowing it to be stored for longer periods. The solution contains citrate to bind calcium, phosphate to buffer pH, dextrose for energy, and adenine to support red blood cell metabolism. These components work together to maintain blood quality.

What precautions apply to Anticoagulant Citrate Phosphate Dextrose Adenine?

Handle CPDA-1 17.3 mg/63mL with care, ensuring proper storage and usage guidelines are followed. Check for any signs of contamination or damage before use. Always follow standard protocols for blood preservation and transfusion to minimize risks.

What does Anticoagulant Citrate Phosphate Dextrose Adenine interact with?

CPDA-1 17.3 mg/63mL may interact with certain medications or substances. Consult healthcare professionals for specific interactions, especially if other anticoagulants or blood-thinning agents are involved. Always follow medical advice for safe and effective use.

Frequently asked questions

What is CPDA-1 17.3 mg/63mL used for?+
CPDA-1 17.3 mg/63mL is used to preserve blood components during storage, ensuring they remain viable for transfusion.
How does CPDA-1 17.3 mg/63mL work?+
This solution contains citrate, phosphate, dextrose, and adenine, which work together to prevent clotting and maintain blood quality.
Can CPDA-1 17.3 mg/63mL be used with other medications?+
Consult healthcare professionals for specific interactions, especially if other anticoagulants or blood-thinning agents are involved.
What precautions should be taken with CPDA-1 17.3 mg/63mL?+
Handle with care, ensuring proper storage and usage guidelines are followed. Check for any signs of contamination or damage before use.
Where is CPDA-1 17.3 mg/63mL manufactured?+
CPDA-1 17.3 mg/63mL is manufactured by Fenwal, Inc. in the USA.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Anticoagulant Citrate Phosphate Dextrose Adenine
Brand
CPDA-1
Strength
17.3 mg/63mL
Form
SOLUTION
Route
INTRAVENOUS
Pack size
63 mL in 1 BAG (0942-9398-02)
Manufacturer
Fenwal, Inc.
Origin
USA

Related products